This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

6 Sep 2012

Clinical experience with Pradaxa® crosses one million patient-years of treatment

Boehringer Ingelheim has announced that the combined treatment experience with Pradaxa? has crossed one million patient-years(1) in the prevention of thromboembolic events in patients after surgery and in patients with non-valvular atrial fibrillation (AF), providing the greatest body of clinical experience among all novel oral anticoagulants.

Related News